Public health assessment of Salmonella enterica serovar enteritidis inactivated-vaccine treatment in layer flocks.
Although there have been several reports on the efficacy assessment of a Salmonella enterica serovar Enteritidis vaccine against intestinal and parenchymatous organ diseases of laying hens, no public health risk characterization of its long-term effect on eggs has been reported. In this study, we attempted to assess the public health effect of an inactivated S. enterica serovar Enteritidis vaccine against serovar Enteritidis contamination of chicken eggs. We analyzed serovar Enteritidis isolation test results from four windowless farms in which inactivated-vaccine administration was initiated based on the sanitary monitoring program of a farm. When flocks with and without S. enterica serovar Enteritidis vaccine treatments were mixed, the application of an inactivated serovar Enteritidis vaccine decreased the most probable number (MPN) of bacteria by at least 100-fold in broken (liquid) egg samples positive for serovar Enteritidis, although a statistical difference between those MPNs could not be obtained. The isolation frequency after the vaccine application was less than 1/10 (P < 0.01). No S. enterica serovar Enteritidis bacteria were isolated approximately 1 year after all of the chickens had received the inactivated serovar Enteritidis vaccine. It was suggested that an adequate administration of an inactivated serovar Enteritidis vaccine reduced the contamination risk of eggs (the number of isolated serovar Enteritidis cells and detection frequency) compared to the contamination risk of eggs laid by nonvaccinated hens.
Toyota-Hanatani
Yukiko
Y
CAF Laboratories, 1257-1 Michinoue-Kannabe, Fukuyama, Hiroshima 720-2104, Japan.
Ekawa
Tomoya
T
Ohta
Hiroaki
H
Igimi
Shizunobu
S
Hara-Kudo
Yukiko
Y
Sasai
Kazumi
K
Baba
Eiichiroh
E
D000818:Animals; D002645:Chickens; D015169:Colony Count, Microbial; D004531:Eggs / Q000382:microbiology*; D011201:Poultry Diseases / Q000517:prevention & control* / Q000635:transmission; D012481:Salmonella Infections, Animal / Q000517:prevention & control* / Q000635:transmission; D022562:Salmonella Vaccines / Q000276:immunology*; D012477:Salmonella enteritidis / Q000276:immunology* / Q000302:isolation & purification*; D015164:Vaccines, Inactivated / Q000276:immunology
D022562:Salmonella Vaccines; D015164:Vaccines, Inactivated